Malakoplakia of the kidney.
Kobayashi
Akimitsu
A
Department of Internal Medicine, Division of Kidney and Hypertension, The Jikei University School of Medicine, Tokyo, Japan. akimitsu@kk.iij4u.or.jp
Utsunomiya
Yasunori
Y
Kono
Midori
M
Ito
Yoriko
Y
Yamamoto
Izumi
I
Osaka
Naoyuki
N
Hasegawa
Toshio
T
Hoshina
Sadayori
S
Yamaguchi
Yutaka
Y
Kawaguchi
Yoshindo
Y
Hosoya
Tatsuo
T
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001706:Biopsy; D015310:Cefotiam / Q000627:therapeutic use; D004269:DNA, Bacterial / Q000032:analysis; D003937:Diagnosis, Differential; D004926:Escherichia coli / Q000235:genetics / Q000302:isolation & purification*; D004927:Escherichia coli Infections / Q000175:diagnosis* / Q000188:drug therapy; D006801:Humans; D007564:Japan; D007668:Kidney / Q000382:microbiology* / Q000473:pathology*; D007674:Kidney Diseases / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology / Q000473:pathology; D008287:Malacoplakia / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology / Q000473:pathology; D008297:Male; D008875:Middle Aged; D016133:Polymerase Chain Reaction; D017422:Sequence Analysis, DNA
D000900:Anti-Bacterial Agents; D004269:DNA, Bacterial; D015310:Cefotiam